glp 1 compound ending FDA Proposes Large-Scale GLP-1 Compounding | Robert Gabbay MD, PhD posted on the topic fda semaglutide ban The FDA
Description
PMID 40471562
Redness (Erythema): A red appearance of the skin, often associated with inflammation
They may see coverage of these drugs as a way to support mental health, reduce absenteeism, and improve overall productivity

Like the injectable form, the Wegovy pill is designed to be taken in smaller doses, before ramping up to a larger dose
I believe this is the group most likely to switch to injectable therapy (Wegovy/Mounjaro), because injections will be seen as a stronger or even a more dependable option

Qsymia primarily targets appetite suppression through stimulant effects, which means it does not address the hormonal and metabolic pathways that drive weight gain
